Health-care companies rose sharply amid hopes that insurers' revenue would not be significantly altered by the tax-and-spending bill that passed the Senate.

Health insurers such as UnitedHealth Group, Humana and Cigna rallied as traders viewed Medicaid cutbacks as relatively modest.

Shares of IGM Biosciences rose after the biotechnology company agreed to be acquired by Concentra Biosciences.

AstraZeneca's chief executive, Pascal Soriot, is considering moving its listing from London to the U.S. due to U.K. restrictions on medicines and pricing, according to The Times of London.


Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

07-01-25 1836ET